Treating immediate hypersensitivity conditions with 3,5-disubsti

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548313, 548314, 562439, 562560, A61K 31415, C07D23378

Patent

active

042307163

ABSTRACT:
Hydantoin compounds are described of the formula (I) : ##STR1## wherein R.sup.1 is phenyl, C.sub.1-4 hydroxyalkyl or carboxy C.sub.1-4 alkyl and wherein R.sub.2 is C.sub.1-6 alkyl. The compounds are useful in the prophylactic treatment of immediate hypersensitivity diseases including asthma.

REFERENCES:
patent: 2626263 (1953-01-01), Gaudry
patent: 2728777 (1955-12-01), Coffman et al.
patent: 3395153 (1968-07-01), Kitasaki et al.
Rutkovskii et al. Chem. Abst. 1970, vol. 72, No. 132613y.
Hassall et al. Chem. Abst. 1972, vol. 76, No. 55564m.
Horner et al. Chem. Abst. 1953, vol. 47, col. 9923.
Knobler et al. Chem. Abst. 1967, vol. 66, No. 86001y.
Dudley et al. I. J. Heterocy. Chem. 1973, vol. 10, pp. 173-180.
Krivtsov et al. Chem. Abst. 1965, vol. 63, col. 669.
Merten et al. Chem. Abst. 1977, vol. 87, No. 102324x.
Suzuki et al. Chem. Abst. 1977, vol. 87, No. 168372t.
Ulsperger et al. Chem. Abst. 1964, vol. 60, cols. 2922-2923.
Dudley et al. II J. Pharm. Exper. Therap. 1970, vol. 175, pp. 27-37.
Knobler, Y., et al., Tetrahedron, 23(3), 1557-1563 (1967).
Hassall, H. et al., Methods Enzymol. 1971, 17 (Pt. B), 95-96, Academic Press, New York.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Treating immediate hypersensitivity conditions with 3,5-disubsti does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treating immediate hypersensitivity conditions with 3,5-disubsti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating immediate hypersensitivity conditions with 3,5-disubsti will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-268113

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.